CannaPharmaRX, Inc.
CPMD
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.71M | 1.36M | 1.13M | 820.10K | 338.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.71M | 1.36M | 1.13M | 820.10K | 338.00K |
| Cost of Revenue | 4.98M | 4.55M | 3.87M | 3.78M | 1.65M |
| Gross Profit | -3.28M | -3.19M | -2.74M | -2.96M | -1.31M |
| SG&A Expenses | 668.60K | 332.80K | 450.80K | 615.40K | -3.40K |
| Depreciation & Amortization | -87.30K | -87.30K | -23.10K | -100.00 | -8.90K |
| Other Operating Expenses | 51.00K | 51.00K | 51.00K | 51.00K | 100.00K |
| Total Operating Expenses | 5.61M | 4.85M | 4.35M | 4.44M | 1.74M |
| Operating Income | -3.91M | -3.49M | -3.22M | -3.62M | -1.40M |
| Income Before Tax | -7.32M | -5.66M | 1.12M | -9.91M | 1.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.32 | -5.66 | 1.12 | -9.91 | 1.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.32M | -5.66M | 1.12M | -9.91M | 1.38M |
| EBIT | -3.91M | -3.49M | -3.22M | -3.62M | -1.40M |
| EBITDA | -2.94M | -3.46M | -3.13M | -3.50M | -1.17M |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.03 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.03 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 2.65B | 2.65B | 2.65B | 2.33B | 2.03B |
| Average Diluted Shares Outstanding | 2.65B | 2.65B | 2.65B | 2.33B | 2.03B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |